Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,246,000 | 9,098,000 | 7,400,000 | 7,571,000 | 11,068,000 |
| Marketable Securities | 795,000 | 796,000 | 75,000 | 4,248,000 | 1,482,000 |
| Inventories | 1,960,000 | 1,909,000 | 2,061,000 | 1,852,000 | 1,682,000 |
| Other current assets | 7,696,000 | 8,532,000 | 9,512,000 | 9,835,000 | 9,970,000 |
| TOTAL | $16,697,000 | $20,335,000 | $19,048,000 | $23,506,000 | $25,131,000 |
| Non-Current Assets | |||||
| PPE Net | 6,010,000 | 5,818,000 | 6,089,000 | 6,425,000 | 6,957,000 |
| Intangibles | 32,531,000 | 26,028,000 | 26,346,000 | 20,842,000 | 22,029,000 |
| Other Non-Current Assets | 3,357,000 | 3,718,000 | 2,051,000 | 2,057,000 | 2,010,000 |
| TOTAL | $41,898,000 | $35,564,000 | $34,486,000 | $29,324,000 | $30,996,000 |
| Total Assets | $58,595,000 | $55,899,000 | $53,534,000 | $52,830,000 | $56,127,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,398,000 | 1,758,000 | 879,000 | 1,990,000 | 125,000 |
| Accounts payable and accrued liabilities | 3,492,000 | 2,499,000 | 2,449,000 | 2,155,000 | 2,580,000 |
| TOTAL | $17,330,000 | $16,051,000 | $13,903,000 | $15,752,000 | $16,787,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,337,000 | 8,516,000 | 9,347,000 | 7,338,000 | 9,097,000 |
| Other Non-Current Liabilities | 11,407,000 | 5,151,000 | 3,479,000 | 3,307,000 | 3,491,000 |
| TOTAL | $21,619,000 | $16,595,000 | $15,679,000 | $13,606,000 | $15,930,000 |
| Total Liabilities | $38,949,000 | $32,646,000 | $29,582,000 | $29,358,000 | $32,717,000 |
| Shareholders' Equity | |||||
| Common Shares | 316,000 | 315,000 | 312,000 | 323,000 | 352,000 |
| Retained earnings | 13,029,000 | 16,960,000 | 17,961,000 | 17,894,000 | 18,272,000 |
| Other shareholders' equity | 1,868,000 | 1,813,000 | 1,807,000 | 1,951,000 | 1,917,000 |
| TOTAL | $19,627,000 | $23,224,000 | $23,737,000 | $23,246,000 | $23,213,000 |
| Total Liabilities And Equity | $58,576,000 | $55,870,000 | $53,319,000 | $52,604,000 | $55,930,000 |